Can we identify genes for susceptibility to diabetic microangiopathies using stroke-prone spontaneously hypertensive rat models?

Mizutani, 1999, Biomechanical properties and chemical composition of the aorta in genetic hypertensive rats, J Hypertens, 17, 481, 10.1097/00004872-199917040-00005 Kojda, 1999, Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure, Cardiovasc Res, 43, 562, 10.1016/S0008-6363(99)00169-8 Bucala, 1991, Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes, J Clin Invest, 87, 432, 10.1172/JCI115014 Romero, 1999, State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension, Hypertension, 34, 943, 10.1161/01.HYP.34.4.943 Griendling, 1998, Redox control of vascular smooth muscle proliferation, J Lab Clin Med, 132, 9, 10.1016/S0022-2143(98)90019-1 Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121 Ceriello, 1999, Hyperglycaemia: the bridge between non- enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications, Diabetes Nutr Metab, 12, 42 Takeuchi, 1999, Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients, Mol Med, 5, 393, 10.1007/BF03402128 Yamagishi, 1998, Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells, Diabetologia, 41, 1435, 10.1007/s001250051089 Yamagishi, 1996, Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors, FEBS Lett, 384, 103, 10.1016/0014-5793(96)00279-7 Zimmerman, 1995, Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine, Proc Natl Acad Sci USA, 92, 3744, 10.1073/pnas.92.9.3744 Cockroft, 1996, Cerebroprotective effects of aminoguanidine in a rodent model of stroke, Stroke, 27, 1393, 10.1161/01.STR.27.8.1393 Yamagishi, 1995, Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy, Biochem Biophys Res Commun, 213, 681, 10.1006/bbrc.1995.2185 Yamagishi, 1993, Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes, Biochem Biophys Res Commun, 191, 840, 10.1006/bbrc.1993.1293 Yamagishi, 1993, Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells, Biochem Biophys Res Commun, 190, 418, 10.1006/bbrc.1993.1064 Yamagishi, 1999, Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor, Microvasc Res, 57, 329, 10.1006/mvre.1999.2145 Segawa, 1998, Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy, Ophthalmic Res, 30, 333, 10.1159/000055493 Yamagishi, 1997, Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor, J Biol Chem, 272, 8723, 10.1074/jbc.272.13.8723 Nomura, 1995, Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes, J Biol Chem, 270, 28316, 10.1074/jbc.270.47.28316 Tsuchida, 1999, Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195, Diabetologia, 42, 579, 10.1007/s001250051198